What will the Danish single-blind HepB vaccine study funded by RFK show?
2
225Ṁ48
2026
48%
Link between HepB vaccine at birth and neurodevelopmental disorders
41%
Link between HepB vaccine at birth and autism spectrum disorder
41%
Link between HepB vaccine at birth and autoimmune diseases
41%
Link between HepB vaccine at birth and allergic conditions
41%
Study is never completed or published
41%
Study results are inconclusive or show no significant differences
41%
Study shows HepB vaccine at birth is safe and effective
41%
Link between HepB vaccine at birth and higher overall death rates
41%
Link between HepB vaccine at birth and increased mortality in females

The Centers for Disease Control and Prevention (CDC) announces the award of

approximately $1,600,000 over a five-year period, in response to an unsolicited proposal

that has been submitted by University of Southern Denmark (SDU). The award will

support a comparable study of the optimal timing and delivery of monovalent Hepatitis B

vaccinations on newborns in Guinea-Bissau. Activities will include conducting a single-blind

randomized controlled trial to assess the effects of neonatal Hepatitis B vaccination on

early-life mortality, morbidity, and long-term developmental outcomes. The award is in

response to an unsolicited proposal.

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy